Platelet adhesion and aggregation in diabetes mellitus.

Area of Science:

• Biochemistry
• Hematology
• Endocrinology

Background:

• Diabetes mellitus is associated with increased risk of vascular complications.
• Platelet activation and aggregation play a crucial role in thrombogenesis and atherosclerosis.

Purpose of the Study:

• To investigate platelet and plasma abnormalities in diabetic patients.
• To explore the potential contribution of these abnormalities to accelerated vascular disease in diabetes.

Main Methods:

• Assessed platelet adhesiveness and sensitivity to aggregating agents.
• Measured plasma levels of von Willebrand Factor (vWF) and factor VIII antigen/activity.
• Investigated plasma factors enhancing adenosine diphosphate (ADP)-induced platelet aggregation.
• Examined platelet sensitivity to arachidonic acid and antiplatelet effects of thromboxane synthetase inhibitors.

Main Results:

• Diabetic platelets showed increased adhesiveness and aggregation.
• Elevated plasma levels of vWF and factor VIII antigen were observed, but not factor VIII procoagulant activity.
• Plasma from 50% of male diabetics enhanced ADP-induced platelet aggregation.
• Diabetic platelets exhibited increased sensitivity to arachidonic acid and decreased sensitivity to thromboxane synthetase inhibition, suggesting increased thromboxane A2 synthesis.

Conclusions:

• Platelet and plasma abnormalities in diabetics, including enhanced aggregation and elevated vWF, may contribute to vascular disease.
• Further research into platelet function and antiplatelet therapies is warranted for diabetic patients.